Literature DB >> 8390424

Establishment of a human small cell lung carcinoma cell line carrying amplification of c-myc gene and chromosomal translocation of t(3p;6p) and t(12q;17p).

A Kato1, T Kamiyama, S Yamaguchi, K Sudo, S Mori, M Sekiguchi, N Aoki, M Shibuya.   

Abstract

A transplantable tumor and an in vitro culture cell line (GK-T3) were established from metastatic liver tissue of human small cell lung carcinoma (SCLC). Southern blot analysis revealed about 30-fold amplification of c-myc gene in the tumor cells in liver, xenografts, and in vitro cell line. The degree of c-myc amplification was essentially conserved through serial passages in nude mice and cultivation in vitro. The level of c-myc mRNA was significantly increased in these cells. Cytogenetically, numerical and complex structural abnormalities were observed in GK-T3 cells, including t(3p;6p), t(12q;17p), two homogeneously staining regions (hsrs) and several double minutes (dmins). These results suggest that activation of c-myc gene and alteration of gene(s) around these chromosomal breakpoints may play a role in tumorigenesis of GK-T3 SCLC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390424      PMCID: PMC5919310          DOI: 10.1111/j.1349-7006.1993.tb00143.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  Three distinct regions involved in 3p deletion in human lung cancer.

Authors:  K Hibi; T Takahashi; K Yamakawa; R Ueda; Y Sekido; Y Ariyoshi; M Suyama; H Takagi; Y Nakamura; T Takahashi
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

2.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors.

Authors:  B E Johnson; A Y Sakaguchi; A F Gazdar; J D Minna; D Burch; A Marshall; S L Naylor
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 3.  Double minutes and homogeneously staining regions: gene amplification in mammalian cells.

Authors:  J K Cowell
Journal:  Annu Rev Genet       Date:  1982       Impact factor: 16.830

4.  myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

Authors:  B E Johnson; D C Ihde; R W Makuch; A F Gazdar; D N Carney; H Oie; E Russell; M M Nau; J D Minna
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.

Authors:  K Saksela; J Bergh; V P Lehto; K Nilsson; K Alitalo
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

6.  Gene amplification of c-myc and N-myc in small cell carcinoma of the lung.

Authors:  A J Wong; J M Ruppert; J Eggleston; S R Hamilton; S B Baylin; B Vogelstein
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

7.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.

Authors:  R Watson; M Oskarsson; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC).

Authors:  J Whang-Peng; P A Bunn; C S Kao-Shan; E C Lee; D N Carney; A Gazdar; J D Minna
Journal:  Cancer Genet Cytogenet       Date:  1982-06

10.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

Authors:  J Yokota; M Wada; Y Shimosato; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.